Home
/
Apyx Medical Corp
/
Financials
/
Quarterly
Apyx Medical Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Apyx Medical Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$12.88M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$11.37M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$9.43M
May 8, 2025
Q3
2025
Sep 30, 2024
$11.49M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$12.15M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$10.24M
May 8, 2025
Q3
2024
Sep 30, 2023
$11.98M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$13.57M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$12.14M
May 9, 2024
Q3
2023
Sep 30, 2022
$9.11M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$10.29M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$12.49M
May 11, 2023
Q3
2022
Sep 30, 2021
$11.83M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$11.22M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$8.64M
May 12, 2022
Q3
2021
Sep 30, 2020
$6.95M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$4.30M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$5.00M
May 12, 2021
Q3
2020
Sep 30, 2019
$7.58M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$6.65M
Aug 10, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2018
$3.67M
Nov 2, 2018
Q2
2018
Jun 30, 2018
$11.48M
Aug 1, 2018
Q1
2018
Mar 31, 2018
$9.92M
May 15, 2018
Q3
2018
Sep 30, 2017
$2.65M
Nov 2, 2018
Q2
2018
Jun 30, 2017
$9.80M
Aug 1, 2018
Q1
2018
Mar 31, 2017
$8.39M
May 15, 2018
Q3
2017
Sep 30, 2016
$10.06M
Nov 3, 2017
Q2
2017
Jun 30, 2016
$9.30M
Aug 3, 2017
Q1
2017
Mar 31, 2016
$7.78M
May 15, 2017
Q3
2016
Sep 30, 2015
$7.82M
Oct 27, 2016
Q2
2016
Jun 30, 2015
$7.27M
Aug 2, 2016
Q1
2016
Mar 31, 2015
$6.13M
May 11, 2016
Q3
2015
Sep 30, 2014
$6.79M
Nov 5, 2015
Q2
2015
Jun 30, 2014
$6.95M
Aug 7, 2015
Q1
2015
Mar 31, 2014
$6.48M
May 8, 2015
Q3
2014
Sep 30, 2013
$5.79M
Nov 10, 2014
Q2
2014
Jun 30, 2013
$6.04M
Aug 8, 2014
Q1
2014
Mar 31, 2013
$5.70M
May 15, 2014
Q3
2013
Sep 30, 2012
$6.67M
Nov 14, 2013
Q2
2013
Jun 30, 2012
$7.44M
Sep 25, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.98M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($3.78M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($4.15M)
May 8, 2025
Q3
2025
Sep 30, 2024
($4.70M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($6.56M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($7.58M)
May 8, 2025
Q3
2024
Sep 30, 2023
($4.63M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($994.0K)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($3.48M)
May 9, 2024
Q3
2023
Sep 30, 2022
($5.76M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($5.43M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($5.95M)
May 11, 2023
Q3
2022
Sep 30, 2021
($4.22M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($4.05M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($4.90M)
May 12, 2022
Q3
2021
Sep 30, 2020
($3.73M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($4.69M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($1.95M)
May 12, 2021
Q3
2020
Sep 30, 2019
($4.37M)
Nov 9, 2020
Q2
2019
Jun 30, 2019
($4.34M)
Aug 7, 2019
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($832.0K)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($2.57M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($3.05M)
May 8, 2025
Q3
2025
Sep 30, 2024
($3.64M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($5.55M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($6.62M)
May 8, 2025
Q3
2024
Sep 30, 2023
($4.64M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($1.24M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($5.61M)
May 9, 2024
Q1
2023
Dec 31, 2022
($23.60M)
May 11, 2023
Q2
2023
Dec 31, 2022
($23.60M)
Aug 11, 2023
Q3
2023
Dec 31, 2022
($23.60M)
Nov 9, 2023
Q3
2023
Sep 30, 2022
($5.78M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($5.98M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($5.87M)
May 11, 2023
Q3
2022
Sep 30, 2021
($3.97M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($4.04M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($4.75M)
May 12, 2022
Q3
2021
Sep 30, 2020
($4.37M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($6.17M)
Aug 12, 2021